CD4+CD25+ T Cells:Reservoir of Productive FIV Infection
CD4+CD25+ T Cells:Reservoir of Productive FIV Infection
批准号:
7224876
负责人:
Wayne A Tompkins
金额:
$33.15万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-05-01 至 2008-04-30
关键词:
AcuteAddressAffectAntibodiesApoptosisBiological AssayBlocking AntibodiesCD4 Positive T LymphocytesCDKN1A geneCTLA4 geneCell CycleCell SeparationCell SurvivalCell physiologyCellsCharacteristicsChronicClinicalCoculture TechniquesCollecting CellColorCytokine SignalingDetectionDominant-Negative MutationDyesEMSAEnvironmentEnzyme-Linked Immunosorbent AssayFamilyFamily FelidaeFeline Immunodeficiency VirusFelis catusFlow CytometryFluorescent DyesHIVHIV InfectionsHIV-1Highly Active Antiretroviral TherapyIL2 geneIL2RA geneIL4 geneImmune responseIn Situ Nick-End LabelingIn VitroIndividualInfectionInterleukin 2 ReceptorInterleukin-10Interleukin-2Interleukin-4LongevityMessenger RNAMitogen-Activated Protein KinasesMitogensMolecularNumbersPathway interactionsPatientsPeptidesPeripheral Blood Mononuclear CellPhenotypePlasmaPolymerase Chain ReactionPopulationPredispositionProductionPropidium DiiodideProteinsResearch PersonnelResistanceReverse Transcriptase Polymerase Chain ReactionRoleSignal PathwaySorting - Cell MovementSpeedStagingStaining methodStainsStandards of Weights and MeasuresSuppressor-Effector T-LymphocytesSurfaceT-LymphocyteT-Lymphocyte SubsetsTimeTranscription Factor AP-1Transforming Growth Factor betaVirusWestern Blottingactivating transcription factoranergyannexin A5cyclin-dependent kinase inhibitor 1Bcytokinedesignin vivoinhibitor/antagonistinsightlatent infectiononcoprotein p21programsprotein expressionreceptorresearch studyresponseuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): A reservoir of on-going HIV replication persists in essentially all patients receiving HAART. Early studies identified a unique CD4+CD25+ T cell as a potential target of productive HIV infection. Similarly, CD4+CD25+ but not CD4+CD25- T cells from FIV-infected cats support a productive FIV infection in vitro and in vivo. These CD4+CD25+ cells have the characteristics of T regulatory (Treg) cells in that they are anergic and suppress T cell proliferative responses to mitogen. These experiments will define the cytokines and intracellular signaling pathways that regulate Treg cells and determine how these molecules may promote FIV replication. PBMC and LN CD4+ T cells from FIV+ and FIV- cats will be analyzed by multi-color flow cytometry with specific antibodies (e.g. CD25, B7.1, B7.2, CTLA4, MHCII and TGFbeta) to identify specific subsets of CD4+ cells. Multiparameter high speed cell sorting using mAb to these receptors (e.g. alphaCD4 to alphaCD25 to Beta7.1) will provide CD4+CD25+ and CD4+CD25- T cell subsets from FIV+ cats for determination of latent or productive infection by PCR and p24 analysis. Purified CD4+ T cell subsets from FIV+ and FIV- cats will also be analyzed for cytokine (e.g. IL10, IL2, TGFbeta, IL4 and IFNgamma) expression by TaqMan PCR and flow cytometry staining. Antibody blocking studies with alphalL10 and alphaTGFbeta will determine their role in maintaining the CD4+CD25+ anergic state and FIV replication capability. Effects of in vivo and in vitro FIV infection on CD4+CD25+ Treg cell function and viability will be established by correlating virus burden with a) anergy (PI staining, 3HTdR uptake); b) susceptibility to apoptosis (Anexin V, TUNEL); and c) suppressor activity against mitogen- or FIV peptide-stimulated CD4+CD25- Th cells; and longevity in culture (CFDA SE staining). Finally, CD4+CD25+ and CD4+CD25- will be analyzed for expression of p21 cip1 and p27 kip1 cdk inhibitors of G1 cell cycling and ATF and AP-1 transcription factor to correlate expression of these protein with CD4+CD25+ T cell anergy and FIV replication. Modulation of expression of these proteins will establish cause and effect relationships between proteins regulating anergy and FIV replication. Cats with acute FIV infection will be analyzed temporally for CD4+CD25+ activation and establishment of a FIV reservoir. These studies should yield insights into the cytokines and signaling pathways that maintain the anergic state of Treg cells and help define the molecular environment that promotes FIV replication and how soon CD4+CD25+ Treg cells are activated and establish a FIV reservoir after infection.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Cloning of feline FOXP3 and detection of expression in CD4+CD25+ regulatory T cells.
猫科动物 FOXP3 的克隆和 CD4 CD25 调节性 T 细胞表达的检测。
DOI:
10.1016/j.vetimm.2007.11.007
发表时间:
2008
期刊:
Veterinary immunology and immunopathology
影响因子:
1.8
作者:
[Lankford,Susan, Petty,Christopher, LaVoy,Alora, Reckling,Stacie, Tompkins,Wayne, Dean,GreggA]
通讯作者:
Dean,GreggA
CD+CD25+ T Cells:Reservoir of Productive FIV Infection
-
批准号:6888542
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2004
-
负责人:Wayne A Tompkins
-
依托单位:
CD+CD25+ T Cells:Reservoir of Productive FIV Infection
-
批准号:7066455
-
项目类别:
-
资助金额:$8.14万
-
财政年份:2004
-
负责人:Wayne A Tompkins
-
依托单位:
CD+CD25+ T Cells:Reservoir of Productive FIV Infection
-
批准号:7054124
-
项目类别:
-
资助金额:$40.04万
-
财政年份:2004
-
负责人:Wayne A Tompkins
-
依托单位:
CD4+CD25+ T Cells:Reservoir of Productive FIV Infection
-
批准号:6841800
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2004
-
负责人:Wayne A Tompkins
-
依托单位:
FIV/HIV IMMUNOPATHOGENESIS--A CASE FOR THE CD8+ CELL
-
批准号:6052871
-
项目类别:
-
资助金额:$6.18万
-
财政年份:1998
-
负责人:Wayne A Tompkins
-
依托单位:
FIV/HIV IMMUNOPATHOGENESIS--A CASE FOR THE CD8+ CELL
-
批准号:6170805
-
项目类别:
-
资助金额:$32.54万
-
财政年份:1998
-
负责人:Wayne A Tompkins
-
依托单位:
FIV/HIV IMMUNOPATHOGENESIS--A CASE FOR THE CD8+ CELL
-
批准号:6532755
-
项目类别:
-
资助金额:$29.73万
-
财政年份:1998
-
负责人:Wayne A Tompkins
-
依托单位:
FIV/HIV IMMUNOPATHOGENESIS--A CASE FOR THE CD8+ CELL
-
批准号:2718287
-
项目类别:
-
资助金额:$27.96万
-
财政年份:1998
-
负责人:Wayne A Tompkins
-
依托单位:
FIV/HIV IMMUNOPATHOGENESIS--A CASE FOR THE CD8+ CELL
-
批准号:2887851
-
项目类别:
-
资助金额:$31.78万
-
财政年份:1998
-
负责人:Wayne A Tompkins
-
依托单位:
FIV/HIV IMMUNOPATHOGENESIS--A CASE FOR THE CD8+ CELL
-
批准号:6373963
-
项目类别:
-
资助金额:$33.52万
-
财政年份:1998
-
负责人:Wayne A Tompkins
-
依托单位:
EVALUATION OF IMMUNE THERAPIES FOR AIDS
-
批准号:2555975
-
项目类别:
-
资助金额:$66.69万
-
财政年份:1992
-
负责人:Wayne A Tompkins
-
依托单位:
EVALUATION OF IMMUNE THERAPIES FOR AIDS
-
批准号:6083452
-
项目类别:
-
资助金额:$4.0万
-
财政年份:1992
-
负责人:Wayne A Tompkins
-
依托单位:
EVALUATION OF IMMUNE THERAPIES FOR AIDS
-
批准号:2295741
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1992
-
负责人:Wayne A Tompkins
-
依托单位:
EVALUATION OF IMMUNE THERAPIES FOR AIDS
-
批准号:2295744
-
项目类别:
-
资助金额:$66.05万
-
财政年份:1992
-
负责人:Wayne A Tompkins
-
依托单位:
EVALUATION OF IMMUNE THERAPIES FOR AIDS
-
批准号:2879668
-
项目类别:
-
资助金额:$8.0万
-
财政年份:1992
-
负责人:Wayne A Tompkins
-
依托单位:
EVALUATION OF IMMUNE THERAPIES FOR AIDS
-
批准号:2682068
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1992
-
负责人:Wayne A Tompkins
-
依托单位:
EVALUATION OF IMMUNE THERAPIES FOR AIDS
-
批准号:2295742
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1992
-
负责人:Wayne A Tompkins
-
依托单位:
EVALUATION OF IMMUNE THERAPIES FOR AIDS
-
批准号:2295739
-
项目类别:
-
资助金额:$60.43万
-
财政年份:1992
-
负责人:Wayne A Tompkins
-
依托单位:
EVALUATION OF IMMUNE THERAPIES FOR AIDS
-
批准号:2295740
-
项目类别:
-
资助金额:$51.07万
-
财政年份:1992
-
负责人:Wayne A Tompkins
-
依托单位:
EVALUATION OF IMMUNE THERAPIES FOR AIDS
-
批准号:6153516
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1992
-
负责人:Wayne A Tompkins
-
依托单位:
海外基金